MetaStat is a precision medicine company dedicated to transforming the treatment of patients with aggressive cancer. Our mission is to evolve cancer treatment into a manageable disease through targeted therapies that arrest cancer cell dissemination and metastatic progression. Aggressive cancer that spreads or metastasizes to other parts of the body is responsible for approximately of cancer related deaths, yet there are no anti metastatic drugs on the market. MetaStat s drug discovery program is focused on developing novel drug candidates that target the Mena dependent metastatic cascade. MetaStat is developing novel small molecule and peptide based kinase inhibitors that target the MAPKAPK pathway responsible for activation of Mena. The company s Mena CDx companion diagnostic assay identifies patients with Mena high tumors at risk for cancer metastasis and most likely to benefit from anti Mena therapy. MetaStat is based in Boston, MA.
Quote | MetaStat Inc (OTCMKTS:MTST)
Last: | $0.0001 |
---|---|
Change Percent: | 0.0% |
Open: | $0.0001 |
Close: | $0.0001 |
High: | $0.0001 |
Low: | $0.0001 |
Volume: | 113 |
Last Trade Date Time: | 07/27/2023 03:00:00 am |
News | MetaStat Inc (OTCMKTS:MTST)
Message Board Posts | MetaStat Inc (OTCMKTS:MTST)
Subject | By | Source | When |
---|---|---|---|
CRAZY GOOD NEWS TODAY . PLUS $LOW FLOAT | lowfloatmaster | investorshub | 06/21/2018 1:51:23 PM |
$MTST: effective Oct 8,2015 a one for 15 | Renee | investorshub | 10/07/2015 1:15:34 PM |
Things are looking good! I'm pleased so | basssque | investorshub | 09/03/2015 4:37:52 PM |
Moon shot for $MTST today? | hal8445 | investorshub | 09/02/2015 9:06:46 PM |
NEWS: Positive results of MenaCalc | makinezmoney | investorshub | 09/02/2015 1:59:07 PM |
News, Short Squeeze, Breakout and More Instantly...